Literature DB >> 10488651

[Latex allergy in a population at risk].

M Ruiz Fernández1, G Flores Sandoval, M Orea Solano.   

Abstract

BACKGROUND: The allergy to latex is an illness whose prevalence has been increased in very significant form in the last years.
OBJECTIVE: To know the allergy incidence to latex in population of risk, as well as to identify the related sintomatology and the importance or paper that play the atopia antecedents and time of contact with latex for the development of the illness.
METHOD: We carry out a prospective, descriptive, experimental and traverse study in population of risk, in the service of Allergy and clinical Immunology of the Hospital Regional Lic. Adolfo López Mateos, ISSSTE. One hundred patients of both sexes were included, with age of 20 to 50 years, with the antecedent of being personal medical and paramedic and to have presented contact with latex material in a minimum period of one year. They were carried out clinical history with registration of sintomatology nasal, bronchial, cutaneous and associated to contact with latex. They were carried out cutaneous test for prick to latex with positive control with the help of histamine solution and negative control with solution of Evans and immediate reading of the same one.
RESULTS: 22% of the patients in study, they presented positive skin test latex, with a time of exhibition 10 year-old average, 68% presented antecedent of atopy personal, family and, likewise the associate sintomatology was in a 33.3% dermatology, 54.5 nasal, nobody presented bronchial symptoms and a 9% asymptomatic was reported.
CONCLUSION: We support that the immediate skin test latex for Prick is an important parameter of support diagnosis for allergy to type 1 latex.

Entities:  

Mesh:

Year:  1999        PMID: 10488651

Source DB:  PubMed          Journal:  Rev Alerg Mex        ISSN: 0002-5151


  1 in total

1.  Hevein, an allergenic lectin from rubber latex, activates human neutrophils' oxidative burst.

Authors:  E Rojas; P Llinas; A Rodríguez-Romero; C Hernández; M Linares; E Zenteno; R Lascurain
Journal:  Glycoconj J       Date:  2001-04       Impact factor: 2.916

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.